Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested â papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: âNivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokineticsâCheckMate 908â.
François Doz, Nicholas K. Foreman, Darren Hargrave, Ălvaro Lassaletta, NicolĂĄs AndrĂ© +14 more